Clinical Trial

India HIV-CervCa Project

Name: India HIV-CervCa Project — clinical trial record (NCT07167069)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting

View on ClinicalTrials.gov →

Record status

This record was last updated September 11, 2025 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.

Summary

The investigators propose to prospectively study the difference in treatment (CTRT) completion and toxicities between HIV positive and HIV negative women in India with locally advanced cervical cancer receiving CTRT.

Trial Details

NCT Number	NCT07167069
Lead Sponsor	Abramson Cancer Center at Penn Medicine Collaborators: Tata Memorial Hospital, National Institute of Allergy and Infectious Diseases (NIAID)
Conditions	HIV Positive, HIV Negative, Cervical Cancer
Enrollment	180 participants
Start Date	2021-02-09
Primary Completion	2026-05 (estimated)
Study Completion	2026-05 (estimated)
Updated on ClinicalTrials.gov	2025-09-11